首页> 外文期刊>World Journal of Gastroenterology >Pituitary adenylate cyclase activating-peptide and its receptor antagonists in development of acute pancreatitis in rats.
【24h】

Pituitary adenylate cyclase activating-peptide and its receptor antagonists in development of acute pancreatitis in rats.

机译:垂体腺苷酸环化酶激活肽及其受体拮抗剂在大鼠急性胰腺炎的发展中。

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: Pituitary adenylate cyclase activating-peptide (PACAP) is a late member of the secretin/glucagon/vasoactive intestinal peptide (VIP) family of brain-gut peptides. It is unknown whether PACAP takes part in the development of acute pancreatitis and whether PACAP or its antagonists can be used to suppress the progression of acute pancreatitis. We investigated the actions of PACAP and its receptor antagonists in acute pancreatitis on rats. METHODS: Acute pancreatitis was induced in rats with caerulein or 3.5% sodium taurocholate. The rats were continuously infused with 5-30 microg/kg PACAP via jugular vein within the first 90 min, while 10-100 microg/kg PACAP6-27 and (4-Cl-D-Phe6, Leu17) VIP (PACAP receptor antagonists) were intravenously infused for 1 h. Biochemical and histopathological assessments were made at 4 h after infusion. Pancreatic and duodenal PACAP concentrations were determined by enzyme-linked immunosorbent assay (ELISA). Chinese ink-perfused pancreas was fixed, sectioned and cleared for counting the functional capillary density. RESULTS: PACAP augmented caerulein-induced pancreatitis and failed to ameliorate sodium taurocholate-induced pancreatitis. ELISA revealed that relative concentrations of PACAP in pancreas and duodenum were significantly increased in both sodium taurocholate- and caerulein-induced pancreatitis compared with those in normal controls. Unexpectedly, PACAP6-27 and (4-Cl-D-Phe6, Leu17) VIP could induce mild acute pancreatitis and aggravate caerulein-induced pancreatitis with characteristic manifestations of acute hemorrhagicecrotizing pancreatitis. Functional capillary density of pancreas was interpreted in the context of pancreatic edema, and calibrated functional capillary density (calibrated FCD), which combined measurement of functional capillary density with dry weight/wet weight ratio, was introduced. Hyperemia or congestion, rather than ischemia, characterized pancreatic microcirculatory changes in acute pancreatitis. CONCLUSION: PACAP may take part in the pathogenesis of acute pancreatitis in rats. The two PACAP receptor antagonsits might act as partial agonists. Calibrated functional capillary density can reflect pancreatic microcirculatory changes in acute pancreatitis.
机译:目的:垂体腺苷酸环化酶激活肽(PACAP)是脑肠肽的促胰液素/胰高血糖素/血管活性肠肽(VIP)家族的晚期成员。 PACAP是否参与急性胰腺炎的发展以及PACAP或其拮抗剂是否可用于抑制急性胰腺炎的进展尚不清楚。我们调查了PACAP及其受体拮抗剂在大鼠急性胰腺炎中的作用。方法:大鼠以青霉素或3.5%牛磺胆酸钠治疗急性胰腺炎。在最初的90分钟内,通过颈静脉向大鼠连续注入5-30微克/千克PACAP,而10-100微克/千克PACAP6-27和(4-Cl-D-Phe6,Leu17)VIP(PACAP受体拮抗剂)静脉输注1小时。输注后4小时进行生化和组织病理学评估。胰腺和十二指肠PACAP浓度通过酶联免疫吸附测定(ELISA)确定。固定,切开和清除中国墨水灌注的胰腺,以计算功能性毛细血管密度。结果:PACAP加重了由青霉素引起的胰腺炎,但未能改善牛磺胆酸钠引起的胰腺炎。 ELISA显示,牛磺胆酸钠和青霉素诱发的胰腺炎与正常对照组相比,胰腺和十二指肠中PACAP的相对浓度显着增加。出乎意料的是,PACAP6-27和(4-Cl-D-Phe6,Leu17)VIP可以诱发轻度急性胰腺炎,并加重由油青素引起的胰腺炎,并具有急性出血/坏死性胰腺炎的特征。在胰腺水肿的背景下解释了胰腺的功能性毛细血管密度,并引入了校准的功能性毛细血管密度(校准的FCD),该功能结合了功能性毛细血管密度的测量与干重/湿重之比。充血或充血而不是局部缺血是急性胰腺炎中胰腺微循环改变的特征。结论:PACAP可能参与了大鼠急性胰腺炎的发病机制。两种PACAP受体拮抗药可能充当部分激动剂。校准后的功能性毛细血管密度可反映急性胰腺炎中胰腺微循环的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号